vialroom

#cagrilintide 2026-01-29

Thursday40 messages12 participantstimes are UTC
Highlights from this day
  • stack_sceptic — its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake 21:40
  • stack_sceptic — monotherapy was underwhelming for me and i say that as someone who wanted it to work changed my mind on this, i started thinking amylin was the interesting bit and… 21:54
  • iris_imports — the fullness effect hasnt faded over 6 months, unlike my semaglutide appetite curve 22:01
  • amsterdam_aliquot — the reason nausea reads differently is timing, mine arrived on the second day rather than the first, take that with a pinch of salt 22:13
WT

follow up is the combination just the two dosed together or a single formulation

£120 for a 30 vial and it lasts me longer than the GLP-1 does at my doses

held at 15 for 9 months on monotherapy before i touched it again
its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

📉5
WT

while im here is there a reason people titrate this over more weeks than the others

CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it

📈3🧪1

the numbers everyone quotes come from the combination, so comparing them to monotherapy logs is unfair

SS

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

💀14🤝1

anyone holding at 2.4 for a while before stepping

is the slower titration because of nausea or something else

added it to an existing semaglutide dose rather than starting both, which made attribution possible

vial-e-2205-front.png
900 × 1200 · 504 KB · not retained in the public archive
SS

monotherapy was underwhelming for me and i say that as someone who wanted it to work
changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing

🙏14

REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work, ask me again in a month

the fullness effect hasnt faded over 6 months, unlike my semaglutide appetite curve

🤝9❤️11🧊1
AA

the reason nausea reads differently is timing, mine arrived on the second day rather than the first, take that with a pinch of salt

🧪1📉13🔥15

the slower titration in here is community habit as much as anything, the trials had their own schedule

amylin is about slowed gastric emptying and satiety signalling, thats the short version and im no pharmacologist

CO

if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way

🔥9

the nausea felt different rather than less, more fullness and less of the queasy wave

VB

Channel stats, last 30 days: 98 messages from 44 members.

CC

stopped for 21 months and the fullness went within a fortnight of the last dose

C1

weekly for me, same day every week, no reason beyond habit

TT

slightly off topic but did the combination change your GI compared to the GLP-1 alone

TT

the fullness thing is the part people describe differently, food stops being interesting rather than repellent
monotherapy did work for me, just slower and smaller than i expected

PP

i titrated over twice as many weeks as i did on semaglutide and that was right for me
the fullness effect hasnt faded over 2 months, unlike my semaglutide appetite curve

CO

nobody should copy my schedule, im describing it because people asked what a slow ramp looks like, anyway